Alkermes (ALKS) Retained Earnings (2011 - 2026)
Alkermes (ALKS) reported Retained Earnings of -$2.9 million for Q1 2026, up 99.7% year-over-year from -$1.5 million in Q1 2025, and down 38.48% quarter-over-quarter from -$2.1 million in Q4 2025.
Alkermes (ALKS) Retained Earnings (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Retained Earnings data on file, last reported at -$2.9 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$2.9 million, up 99.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.9 million (up 99.7% YoY), and the FY2025 annual result was -$2.1 million, up 99.78% from the prior year.
- Retained Earnings slipped to -$2.9 million in Q1 2026 per ALKS's latest filing, from -$2.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $425000.0 in Q3 2024 and troughed at -$1.7 billion in Q1 2023.
- A 5-year average of -$780.9 million and a median of -$954.0 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 80767.74% in 2022, then jumped 100.03% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$10.9 million in 2022, then sank by 12238.4% to -$1.3 billion in 2023, then increased by 27.32% to -$976.5 million in 2024, then jumped by 99.78% to -$2.1 million in 2025, then sank by 38.48% to -$2.9 million in 2026.
- Business Quant data shows ALKS's Retained Earnings at -$2.9 million in Q1 2026, -$2.1 million in Q4 2025, and -$1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -573.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.91 Mn |
| Dec 31, 2025 | -2.10 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -866.90 Mn |
| Mar 31, 2025 | -953.99 Mn |
| Dec 31, 2024 | -976.46 Mn |
| Sep 30, 2024 | 425,000.00 |
| Jun 30, 2024 | -1.22 Bn |
| Mar 31, 2024 | -3.60 Mn |
| Dec 31, 2023 | -1.34 Bn |
| Sep 30, 2023 | -1.46 Bn |
| Jun 30, 2023 | -1.50 Bn |
| Mar 31, 2023 | -1.74 Bn |
| Dec 31, 2022 | -10.89 Mn |
| Sep 30, 2022 | -12.84 Mn |
| Jun 30, 2022 | -1.61 Bn |
| Mar 31, 2022 | -1.58 Bn |
| Dec 31, 2021 | -1.54 Bn |
| Sep 30, 2021 | -1.54 Bn |
| Jun 30, 2021 | -2.22 Mn |